Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Shandong Pharmaceutical Glass Co's PEG Ratio or its related term are showing as below:
SHSE:600529'
s PEG Ratio Range Over the Past 10 Years
Min: 0.76 Med: 1.75 Max: 14.96
Current: 2.2
During the past 13 years, Shandong Pharmaceutical Glass Co's highest PEG Ratio was 14.96. The lowest was 0.76. And the median was 1.75.
SHSE:600529's PEG Ratio is ranked worse than 58.18% of 165
companies
in the Packaging & Containers industry
Industry Median: 1.64
vs SHSE:600529: 2.20
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Shandong Pharmaceutical Glass Co (SHSE:600529) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Shandong Pharmaceutical Glass Co PEG Ratio Related Terms
Shandong Pharmaceutical Glass Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Pharmaceutical Glass Co PEG Ratio vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Shandong Pharmaceutical Glass Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Shandong Pharmaceutical Glass Co (SHSE:600529) has a PEG Ratio of 2.20 as of Jul. 18, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Shandong Pharmaceutical Glass Co and its competitors. This is 26% above median its historical median of 1.75. Over the past decade, Shandong Pharmaceutical Glass Co's PEG Ratio has ranged from 0.76 to 14.96. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #96 out of 165 companies in the Packaging & Containers industry, placing it in the top 58.2%.
Is Shandong Pharmaceutical Glass Co's PEG Ratio too high?
Shandong Pharmaceutical Glass Co's current PEG Ratio of 2.20 is 26% above median its 10-year median of 1.75. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 14.96. The Packaging & Containers industry median PEG Ratio is 1.64. Shandong Pharmaceutical Glass Co's value of 2.20 is 34.1% above this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #96 out of 165 companies in the Packaging & Containers industry, which is below the industry midpoint. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's PEG Ratio compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #96 out of 165 companies for PEG Ratio. This places Shandong Pharmaceutical Glass Co in the lower half of its industry. The industry median PEG Ratio is 1.64. Shandong Pharmaceutical Glass Co's value of 2.20 is 34.1% above this benchmark. Historically, Shandong Pharmaceutical Glass Co's own PEG Ratio has ranged from 0.76 to 14.96 over the past decade. While the company's 10-year median is 1.75 vs. the industry median of 1.64, Shandong Pharmaceutical Glass Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Packaging & Containers company?
The median PEG Ratio among Packaging & Containers companies is 1.64, based on 165 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current PEG Ratio of 2.20 is 34.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Shandong Pharmaceutical Glass Co and its competitors. For the Packaging & Containers industry, the median PEG Ratio is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current PEG Ratio is 2.20, which is 26% above median its own 10-year median of 1.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.27, compared to a current price of ¥18.80 — trading 22.5% below its estimated fair value. The current PEG Ratio is 2.20, which is 26% above median its 10-year median of 1.75 and 34.1% above the Packaging & Containers industry median of 1.64. Shandong Pharmaceutical Glass Co's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current PEG Ratio is 2.20 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥18.80 is trading 22.5% below its estimated GF Value™ of ¥24.27.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
PEG Ratio: 2.20 (26% above median its 10-year median of 1.75)
GF Value™: ¥24.27 vs. price of ¥18.80 (22.5% below fair value)
Industry Position: 34.1% above the Packaging & Containers median (#96 of 165)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Business Description
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
89GF Score
Get the complete analysis for SHSE:600529
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
